MGC PHARMACEUTICALS
MGC Pharmaceuticals Ltd. is an Australian Company publicly listed on the ASX (ASX:MXC) founded in early 2015 by leading Israeli medical cannabis industry executives. The goal was establishing a global cannabinoid (CBD) and medical cannabis business utilizing their intellectual property, expertise and contacts, with a focus on the CBD market in Europe and Australia. MGC is operates globally with an agenda of adding value to the whole product chain, from growing and breeding unique strains to developing medicine delivery systems. With the Medical Cannabis industry, and particularly the CBD subsection of this industry booming globally, now is a time where making correct choices in partnerships and associations becomes most crucial.
MGC PHARMACEUTICALS
Industry:
Cannabis Clinical Trials Cosmetics Pharmaceutical
Founded:
2005-01-01
Address:
Perth, Western Australia, Australia
Country:
Australia
Website Url:
http://www.mgcpharma.com.au
Total Employee:
11+
Status:
Active
Contact:
+61893892000
Email Addresses:
[email protected]
Total Funding:
18.77 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Content Delivery Network Wordpress Plugins Sitelinks Search Box Euro
Similar Organizations
Ceva Santé Animale
Ceva Sante Animale is a veterinary health company focused on the research, development, production and marketing of pharmaceutical products.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
GW Pharmaceuticals
GW Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
LivWell Enlightened Health
LivWell Enlightened Health is a medical cannabis company producing and retailing multi-state cannabis.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Employees Featured
Founder
Stock Details
Investors List
Malta Enterprise
Malta Enterprise investment in Grant - MGC Pharmaceuticals
Official Site Inspections
http://www.mgcpharma.com.au Semrush global rank: 9.77 M Semrush visits lastest month: 112
- Host name: 178.62.115.53
- IP address: 178.62.115.53
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "MGC Pharmaceuticals"
Argent BioPharma - Crunchbase Company Profile & Funding
Argent BioPharma is a specialized biopharmaceutical firm that develops and markets novel medications. View contacts for Argent BioPharma to access new leads and connect with …See details»
Home - MGC Pharmaceuticals
We are an internationally recognized WHO-GMP certified and leading Pharmaceutical Contract Manufacturer. We are a pharmaceutical contract development and manufacturing organization …See details»
MGC Pharma Rebrands as Argent BioPharma in Strategic ... - Nasdaq
Feb 13, 2024 · Poised for growth, Argent BioPharma is now set to emerge as a key player in the biopharmaceutical industry, leveraging cutting-edge advancements in Polypharmacology and …See details»
MGC Pharmaceuticals rebrands as Argent BioPharma in strategic
MGC Pharmaceuticals (ASX:MXC) officially rebranded to Argent BioPharma (ASX:RGT) following approval from shareholders for the strategic renaming on March 18.See details»
MGC Pharma Rebrands as Argent BioPharma in Strategic …
Feb 13, 2024 · Marking a significant milestone in its evolutionary journey, MGC Pharma has officially announced its rebranding to Argent BioPharma, pending approval from its shareholders.See details»
MGC PHARMACEUTICALS LTD - ShareCafe
MGC Pharmaceuticals Limited (‘MGC’) (ASX: MXC) is a biopharma company with a “Nature to Medicine” strategy at the forefront of the emerging phytocannabinoid and plant derived …See details»
‘Fully funded’ – MGC Pharma completes share consolidation and …
Nov 10, 2023 · MGC Pharmaceuticals (ASX:MXC) (LSE:MXC) has announced that following shareholder approval at a general meeting, the consolidation of its total issued capital on a …See details»
MGC Pharmaceuticals Limited - AnnualReports.com
MGC Pharmaceuticals Ltd (ASX: MXC) is a European based bio-pharma company developing and supplying affordable standardised phytocannabinoid derived medicines to patients globally.See details»
MGC Pharmaceuticals | ASX-Listed - Cannaus
As a company, their main business goal is the production and supply of high-quality cannabinoid based pharmaceutical products for emerging medical markets in Europe, North America, …See details»
MGC Pharmaceuticals - News, Partnerships, Locations and …
Usearch identified 2 signals for MGC Pharmaceuticals, including: 2 Partnerships. Usearch has identified 1 executive & key decision-maker.See details»
MGC Pharmaceuticals - Craft
Jun 3, 2024 · MGC Pharmaceuticals is a biopharma company focusing on the cannabinoid (CBD) and medical cannabis business. It supplies GMP (good manufacturing practice) …See details»
MGC Pharmaceuticals clarifies share consolidation and new …
Nov 2, 2023 · MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has provided clarity on the company’s consolidation of capital and new fundraising programme.See details»
ASX Code: MXC MGC Pharma’ s 2021 Annual General Meeting …
Oct 25, 2021 · (LSE: MXC, ASX: MXC) is a European based bio-pharma company developing and supplying affordable standardised phytocannabinoid derived medicines to patients globally.See details»
MGC Pharmaceuticals Enters Partnership with Sciensus Rare for ...
Apr 5, 2022 · MGC Pharmaceuticals Ltd (LSE: MXC, ASX: MXC, OTC: MGCLF) is a European based bio-pharma company developing and supplying affordable standardized …See details»
MGC Pharmaceuticals - MXC(ASX) News & Expert Insights from
Nov 15, 2023 · ‘Fully funded’ – MGC Pharma completes share consolidation and ~US$8 million cap raise November 10, 2023 April 2, 2024 | Special Report. Health & Biotech ‘Unwavering …See details»
MXC News, Analysis, Announcements & Results - AFR
Apr 19, 2020 · ASX-listed MGC Pharma has floated in London while Little Green Pharma placed $22 million of shares, as the high-potential European market beckons. Feb 10, 2021; Hans …See details»
MGC Pharmaceuticals Successfully Developed Herbal-inspired …
Sep 21, 2022 · MGC Pharmaceuticals, along with Swiss Pharmacan, have developed two clinically tested herbal-based products that ameliorate the more troublesome symptoms of …See details»
MGC Pharmaceuticals Ltd (ASX:MXC) Share Price - Market Index
MGC Pharmaceuticals Ltd (MXC) is a European based pharmaceutical company, focused on developing and supplying accessible and ethically produced medicines, combining in-house …See details»
MGC Pharmaceuticals – Medium
Oct 5, 2017 · Read writing from MGC Pharmaceuticals on Medium. A global leader in Cannabis-based pharmaceuticals within the Biopharma industry. Every day, MGC Pharmaceuticals and …See details»
MGC Pharmaceuticals Ltd (ASX:MXC) - Price, Chart, …
MGC Pharmaceuticals Limited (ASX:MXC, also listed on US OTCQB) is a European biopharma company supplying GMP Phytocannabinoid derived medicines to patients globally, with a core …See details»